Public Limited Companies – Julia Vinograd Wed, 20 Oct 2021 09:35:32 +0000 en-US hourly 1 Public Limited Companies – Julia Vinograd 32 32 Biotage acquires ATDBio and strengthens its position in the synthesis and purification of DNA and RNA oligonucleotides Wed, 20 Oct 2021 06:39:00 +0000

UPPSALA, Sweden, 20 October 2021 / PRNewswire / – Biotage AB (Released) (“Biotage“) today entered into an agreement to acquire all of the outstanding shares of the private company ATDBio Limited (“ATDBio“) situated at Oxford and Southampton, United Kingdom, for a total purchase price of approx. 45 MGBP on a debt-free and cash-free basis (corresponding to approximately MSEK 534.4[1]) financed by the combination of an issue of new Biotage ordinary shares, available cash and a revolving credit facility. The transaction was closed as part of the conclusion of the share purchase contract.

The acquisition of ATDBio adds important platform solutions to Biotage for the synthesis and purification of DNA and RNA oligonucleotides. This technology is used for applications in drug discovery, molecular diagnostics (such as PCR testing), nucleic acid-based therapies, and next-generation DNA and RNA sequencing technologies. The acquisition of the UK company is expected to significantly expand and strengthen Biotage as a leading life sciences tool and provider of impact technology services. ATDBio was founded by professor Tom Brown father, recognized expert in nucleic acid chemistry, in 2004.

ATDBio’s expertise in the production of highly complex DNA and RNA will provide Biotage with market access and know-how in the rapidly growing sector of DNA and RNA oligonucleotides. This market is currently driven by the demand for high quality DNA and RNA molecules and other oligonucleotide analogues in light of the coronavirus pandemic, as well as the potential for other therapies, vaccines and diagnostics. molecules based on nucleic acid.

We are very happy to welcome ATDBio to the Biotage Group family. Our companies are very complementary and share the same vision to shape the science of tomorrow and the discoveries of tomorrow. Step by step, Biotage is expanding its chemical modalities platforms and portfolio offering. From peptide purification and higher volume small molecule research, we have already expanded to purification of lipids for use in mRNA vaccines as well as purification of plasmid DNA, including viral purification for gene therapy. We are now entering the attractive new oligonucleotide market“, comments Tomas blomquist, CEO and President of Biotage.

ATDBio is very proud to be part of the Biotage family, which shares our passion for innovation, customer focus and sustainability. With our in-depth understanding of nucleic acid chemistry, we can ensure high quality oligonucleotide synthesis and deliver high purity products. We manufacture oligonucleotides for a wide variety of academic and commercial customers, including some of the world’s largest biotech and pharmaceutical companies. We will now be able to grow even further thanks to Biotage’s global presence and cutting-edge expertise in separation science. We will continue to innovate, helping our customers bring the next generation of molecular nucleic acid diagnostics, vaccines and therapeutics to market.“said Dr Tom brown jr, director of ATDBio.

The combination of ATDBio’s specialized and large-scale expertise in DNA and RNA oligonucleotide production and innovation with Biotage’s one-stop workflow and customer platform solutions has great potential. With Biotage having recently gained market share in the large-scale flash purification of lipids used for the formulation of lipid nanoparticles of mRNA vaccines, there is already a successful approach that can be applied for other DNA chemical modalities and of RNA in different drug and therapeutic discoveries. applications. Chemically synthesized RNA is also required for CRISPR / Cas gene editing technology, the discovery and development of which led to the award of the 2020 Nobel Prize in Chemistry.

ATDBio generated a net turnover of 3.5 MGBP in 2020, corresponding to approx. 41.6 MSEK and an operating result (EBIT) of 1.0 MGBP, corresponding to approx. SEK 11.9 million. To be compared with the first nine months of 2021 for a net turnover of 4.5 MGBP. ATDBio had 20 full-time employees at September 30, 2021.

All ATDBio shares are acquired from ATDBio shareholders through a share purchase agreement with Biotage for consideration in shares and cash. The total purchase price of all ATDBio shares is approx. 45 MGBP, corresponding to approx. 534.4 MSEK, on ​​a debt-free and cash-free basis, and includes approx. 16 MGBP (around 190 MSEK) into 781,991 newly issued ordinary shares in Biotage and approx. 29 MGBP (approximately 344.4) MSEK in cash. Of which 5 MGBP (corresponding to approximately 59.4 MSEK) of the total purchase price consists of a future payment of the expected additional purchase price which, in the end, must be paid after three years.

The transaction will be financed by a share issue of 781,991 new Biotage common shares combined with available cash and a revolving credit facility. The issue of shares against contribution in kind was decided today by the Board of Directors of Biotage pursuant to an authorization given by the General Meeting of April 28, 2021. Ordinary shares will be issued to ATDBio shareholders.

This is information that Biotage AB (publ) is required to make public in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the contact person indicated above, at 8:30 a.m. CEST on 20 October 2021.

Contact people:

Tomas blomquist, CEO

Phone: 0705 23 01 63, [email protected]

About Biotage

Biotage is a Global Impact Tech Company committed to solving the problems of society. We provide workflow solutions and products to customers in the areas of drug discovery and development, analytical testing, and water and environmental testing. Biotage contributes to sustainable science with the goal of making the world healthier, greener and cleaner – HumanKind Unlimited.

Our clients cover a wide range of market segments including pharmaceutical, biotechnology, contract and contract research manufacturers, as well as clinical, forensic and academic laboratories, as well as organizations focused on food safety, drinking water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people in the world. The Group achieved sales of MSEK 1,092 in 2020 and our products are sold in more than 70 countries. Biotage (BIOT) shares are listed on the Mid Cap segment of NASDAQ Stockholm.


[1] Based on a SEK / GBP exchange rate of 11.8765, used throughout this press release for the GBP / SEK conversion.

This information was brought to you by Cision synthese-and-pu, c3436384

The following files are available for download:

SOURCE Biotage

Source link

Performance of Shikigaku Co., Ltd. (7049, TSE Mothers) for the first semester ended August 31, 2021 Tue, 19 Oct 2021 02:10:00 +0000

TOKYO, October 18, 2021 / PRNewswire / – Sales and profits increased significantly in the six months ended August 31, 2021. Results were strong in the core business of Consulting, and the Company saw strong performance growth in management consulting and platform services.

Summary of Findings

During the six months ended August 31, 2021, the economic environment in Japan continued to be ruthless due to the impact of the COVID-19 pandemic. However, the market demonstrates a strong need to improve organizational productivity through such means as results-based employee management and rules-based organizational management that generates results regardless of the workplace used. As a result, demand for the Company’s services remains robust.

As part of its business philosophy of “spreading Shikigaku and maximizing the potential of people”, the Shikigaku Group provides services that facilitate the impregnation of its “Shikigaku” organizational management theory within client organizations. In addition, through its Sports Entertainment business, the Company is actively engaged in sales activities aimed at acquiring sponsors for the start of the 2021-2022 season of professional basketball organization B.LEAGUE. In the venture capital fund industry, Aidma Holdings, Inc., the first company in which SHIKIGAKU No. 1 Investment Limited Partnership invested, successfully listed its shares on the TSE Mothers Index. With this listing, two issuers of SHIKIGAKU No. 1 Investment Limited Partnership completed IPOs within a year and a half of its inception. The Company views these results as proof that the Shikigaku organization consulting method supports organizational management aimed at securing public registrations.

For the past six months August 31, 2021, the Company reported net sales of JPY 1,801,483,000 (+ 86.4% YoY), EBITDA (operating income + depreciation and amortization + goodwill amortization + amortization of lease deposits) of 236,142,000 JPY (+ 7,588.7% YoY), operating profit of 201,292,000 JPY (compared to the operating loss of 24,381,000 JPY for the six months ended August 31, 2020), ordinary profit of 197,270,000 JPY (compared to the ordinary loss of JPY25,918,000 for the six months ended August 31, 2020), and 120,333,000 JPY in net income attributable to owners of the parent company (compared to 105,132,000 JPY in net loss for the six months ended August 31, 2020).

The Company has five business segments: the Organizational Consulting business, the Sports Entertainment business, the Contract Development business, the VC Fund business and the Practical Support Fund business.

Through its organizational consulting business, the Company provides management consulting and platform services.

COVID-19 pandemic impacted management consulting services during the closed semester August 31, 2021. However, the Company continued to make investments supported by vigorous marketing activities to facilitate the active recruitment of consultants and the expansion of its client base. As a result, its number of consultants rose to 65, up 11 from the February 28, 2021. From August 31, 2021, the Company indicated that it has entered into management consulting services contracts with a cumulative total of 2,571 companies. Its management consulting services have generated 1,070,358,000 JPY of sales for the six months ended August 31, 2021 (+ 36.5% year-on-year).

During the period under review, in the platform services category, the Company focused on expanding sales of its core SHIKIGAKU services, which provide continuous operational support until management organization based on his Shikigaku theory (corresponding service launched in September 2020) to seize. The diagnostics that accompany these services clarify organizational problems and help support their eventual resolution. As a result, the Company has strived to improve the satisfaction of its customers associated with its basic SHIKIGAKU services. From August 31, 2021, the Company had concluded SHIKIGAKU basic service agreements with 379 companies (compared to 167 at February 28, 2021) while also reporting 157 SHIKIGAKU Cloud agreements (compared to 229 in February 28, 2021) and 340 Shikigaku member clients (compared to 479 in February 28, 2021). Platform services generated 487,545,000 JPY of sales for the six months ended August 31, 2021 (+ 210.5% year-on-year).

As a result of these elements, the turnover of the Organization Consulting activity amounted to 1,558,103,000 JPY (+ 65.5% YoY) while operating profit stood at JPY 294,660,000 (+3,997.2% year-on-year).

In the Sports Entertainment business, the Company has fulfilled its function as a community club by leading initiatives to stimulate and broaden interest in local sports while striving to facilitate team building in the pursuit of promotion at League B1 level. During the three months ended August 31, 2021, the Company expanded its sales activities aimed at acquiring sponsors for the 2021-2022 season, increased the reach of its sales staff recruitment and strengthened its collaboration with local governments to increase tax payments made in as part of the enterprise version of from Japan taxation of the city of origin, which has become a new tax base. In part as a result of these efforts, sponsorship orders have been strong, rising to 9,397,000 JPY (+ 75.8% year-on-year). However, costs outweighed profits during the period under review as the Company continued to invest in operations aimed at strengthening its team.

As a result, the revenue generated by the Sports Entertainment activity amounts to 91,784,000 JPY while the operating loss of the company amounted to JPY75,255,000.

In the contract development activity, the Company has drawn on its sources of engineers and the vast expertise it has cultivated while managing numerous and diverse development projects by carrying out development operations associated with the services of platform of its own group of companies and outsourcing the development of e-learning systems related to certification courses. In March 2021, the company launched Work Experience DX, a recruitment matchmaking service that allows users to simulate the experience of joining participating companies, thereby gaining knowledge of the work they do and an understanding of their compatibility with those companies.

As a result of these factors, the sales generated by the contract development activity amounted to JPY 151,595,000 while the corresponding operating loss amounted to JPY13 752,000.

In the venture capital fund industry, the company has made investments focused on building and expanding organizational power and becoming a growth-generating organization. At the same time, she also operated venture capital funds that support growth by facilitating organizational improvements in the companies they invest in by implementing the Shikigaku theory of the company. In June 2021, the Company established SHIKIGAKU No. 2 Investment Limited Partnership, converted it into a subsidiary and began including its performance in the consolidated financial results. In June and July 2021, the Company sold part of the shares held by SHIKIGAKU No. 1 Investment Limited Partnership and registered a JPY167 million gain on the sale of investment securities, qualifying this gain as extraordinary income because it was generated by an investment made on or before June 29, 2021.

As a result, the operating loss of the VC Fund business amounted to 13,113,000 JPY.

In the Practice Support Fund business, the Company operated practical support funds which provide organizational improvement and financial support and earn income from capital gains generated by the investment exit (IPO, M&A, etc. ). In June 2021, the Company created Shinsei Shikigaku Growth Support I Investment Limited Partnership and converted it to an equity affiliate. The objective of this fund is to invest in companies that are expected to grow, to provide practical support aimed at improving their financial performance and to facilitate this growth, and to raise investment capital through their subsequent sale.

As a result of the expenses associated with these efforts, the Practical Support Fund activity generated an operating loss of 990,000 JPY.

The Company made no changes to its earnings guidance for the year ending February 28, 2022, which projects sales of JPY 3,798 million (+ 51.6% year-on-year), EBITDA of JPY 470 million (+ 136.2% YoY), operating profit of JPY400mn (+ 191.2% year-on-year) and ordinary profit of JPY353mn (+ 77.4% year-on-year).
Shikigaku Co., Ltd. (7049, TSE Mothers)

Please visit the following URL for a summary of the consolidated financial results for the six months ended August 31, 2021
→ https: //

The purpose of this press release is to provide information to serve as a reference for investment decisions and not for the purpose of soliciting investments. Please exercise your own judgment on final decisions such as investment policy, timing and selection. Please note that we take no responsibility for any damages caused by this service.

Borderless IR specializes in the global distribution of IR content, including the delivery of newsletters and annual reports providing the latest news and key strengths of Japanese companies directly to foreign investors through major global media, database services. corporate information and mailing lists. Borderless is also committed to supporting other global IR efforts.

© Borderless IR Co., Ltd. All rights reserved
The content of this press release may not be duplicated or reproduced.

Show original content:


Source link

Will new Covid treatments be as elusive for poor countries as vaccines? Sun, 17 Oct 2021 21:15:06 +0000

“It’s no coincidence that Merck has experience with HIV – internally, with their leadership and their culture, they know that if they don’t meet the access challenges, they will be criticized,” said Dr Moon, co-director of the Global Health Center of the Graduate Institute of International and Development Studies in Geneva.

Generic manufacturing is not in itself a guarantee of global access. Half of all coronavirus infections reported in low- and middle-income countries in the first six months of 2021 occurred in 32 countries excluded from the Merck license. Brazil, Malaysia, Mexico and Peru are not included. China and Russia either.

Generic production licenses for small territories can leave middle-income countries with fragile public health systems paying almost as high prices as rich countries. Merck says it will use the World Bank’s income data from those countries to calculate what it charges for the drug in each.

Merck is also in negotiations with the Medicines Patent Pool, a United Nations-backed nonprofit that works to make medical treatments and technologies accessible. Charles Gore, director of the organization, said he hoped Merck would agree to a licensing deal that could allow companies in an even wider range of locations to manufacture the drug, while Merck sells its own product in rich countries. Such a deal, he said, would set an important precedent for other companies.

If Merck, Pfizer, or other drugmakers do not ensure wide availability of Covid treatments, they could face widespread use of compulsory licensing, in which governments override intellectual property restrictions to allow drug manufacturing. , often in emergency situations. While Merck will levy a royalty on drugs sold by generic manufacturers, and likely also on any deals made through the patent pool, under compulsory licensing, the company has no say in the price. drug or the amount of the fee.

Unitaid, the Geneva-based global health agency, said $ 3.5 billion in new funding from rich countries was needed to make treatments accessible, with most of it going to antivirals in low-income countries. .

“We need a global effort. We need donors to provide funds to ensure treatments reach everyone, ”said Janet Ginnard, Director of Strategy.

Source link

Hertz files for new IPO Sat, 16 Oct 2021 17:06:19 +0000

By Chris Isidore, CNN Business

Hertz becomes public again.

The car rental company, which filed for bankruptcy early in the pandemic and emerged on June 30, has filed documents with the Securities and Exchange Commission for an initial public offering.

The company announced its plans for the IPO in August when it released its second quarter financial results, including revenue that had almost returned to pre-pandemic levels and higher operating profit than ‘before the pandemic. He also had a net loss of $ 168 million caused by $ 633 million in reorganization costs.

The company enjoys a shortage of rental cars that pushes rates up to incredibly high by historical standards.

When the pandemic nearly brought air travel to a halt, car rental companies had far more cars on hand than they needed, so much so that they were forced to rent space in deserted sports stadium car parks to park their fleet. With so few people traveling, companies sold cars into the used car market to raise the money they needed to survive.

Once the demand for travel started to return, automakers were suddenly hit by the shortage of computer chips, which limited the number of new cars they could make. Car rental companies have been unable to rebuild their fleets – a supply chain nightmare that has driven rental rates to record levels.

Rental car prices are down 15% from a record high in June, according to the U.S. Consumer Price Index, the country’s main measure of inflation. But rates were still 51% higher in September than in September 2019, before the pandemic, according to CPI. Few products or services are still well above pre-pandemic levels.

Former Hertz shareholders were virtually wiped out by the bankruptcy. Financier Carl Icahn, its largest shareholder, lost about $ 2 billion on his investment when he sold his shares shortly after filing for bankruptcy.

Within months, however, Hertz gained popularity with many retail investors, making it a first memes stock, a GameStop before the shares of video game retailer GameStop got their own roller coaster ride.

This increase in Hertz shares prompted the company to offer to sell additional shares to raise funds as it struggled to weather the downturn and finance its operations during the pandemic.

Those plans were scrapped when the Securities and Exchange Commission objected, citing the likelihood that shareholders would end up with worthless shares at the end of the bankruptcy process.

™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.

Source link

Harvest Deal with Speedcast to Improve Global Connectivity for Remote Workers Thu, 14 Oct 2021 02:44:00 +0000

Posted: October 13, 2021 at 10:44 PM EDT|Update: 2 hours ago

PERTH, Australia, October 13, 2021 / PRNewswire / – Harvest Technology Group Limited (ASX: HTG), a global leader in network-optimized remote operations, today announced that it has signed an official reseller agreement with Speedcast, a leading service provider IT and communications services, providing critical communications services for remote clients. in sectors such as energy, maritime, mining and telecommunications.

Speedcast and Harvest Technology announce agreement to improve global connectivity for teleworkers.

Half of the world has no high-speed internet, over 30% are 4G-free, the deal helps people, businesses get online

As part of the agreement between the two companies, live streaming solutions optimized for Harvest’s ultra-low bandwidth network will be integrated into Speedcast’s SmartView solution. Harvest’s revolutionary live streaming solutions can securely stream real-time high-definition voice, video and data at ultra-low bandwidth from anywhere in the world, where connectivity is often required. limited or absent.

“Our partnership with Harvest aligns with our vision to continually innovate for the success of our customers,” said Jeffrey Irwin, Vice President, Product Management at Speedcast. “The addition of Harvest’s industry-leading remote video streaming solutions to our portfolio enables remote sites to provide real-time visibility to decision makers around the world, thereby improving operational efficiency, enhancing worker safety and resulting in cost savings. “

The agreement between the two companies will expand Harvest’s sales capabilities globally. Speedcast’s portfolio of technologies and applications currently has more than 3,200 customers in 140 countries, serving more than 10,000 marine vessels and more than 8,000 land-based sites.

Benefits for Speedcast customers using the Harvest solution include increased operational efficiency through faster decision making in the field, at the base, in the office or at home.

“Harvest’s network-optimized live streaming solutions provide the connectivity needed to service and repair equipment, monitor networks and access remote systems from operations centers rather than deploying more people in the field or on site, ”said Paul Guilfoyle, Harvest Technology Group, Group Managing Director.

Employee safety is a priority for organizations with remote workforces. Real-time high-definition voice, video and data delivered through network-optimized live streaming solutions ensure employee safety, ranging from reducing the need for workers to be in high-risk environments, permanent security systems and telehealth services for the unexpected. disease or injury management.

“Almost half of the world still does not have high-speed internet access and over 30% do not have 4G coverage, so we are thrilled to be working with Speedcast to keep their customers all over the world connected. operations and staff. while using a fraction of their existing bandwidth resources, “continued Guilfoyle.” The combination of our ultra-low bandwidth technology and Speedcast’s impressive network will strengthen its global network platform. by delivering fully connected systems that transform remote operations. ”

For all media inquiries, please contact:

Josie taylor
+61 467 764 768

Otto Pijpker

About Speedcast
Speedcast is a leading provider of IT and communications services, providing critical communications services to the marine, energy, mining, media, telecommunications, cruise, NGO, government and corporate industries. The company leverages its global network platform to deliver fully connected systems that leverage technologies and applications to transform what remote operations can achieve. With the world’s most comprehensive network, Speedcast enables faster and seamless pole-to-pole coverage from a global hybrid transport network via satellite, fiber, cellular, microwave, MPLS and IP with direct access to public cloud platforms. The company incorporates differentiated technology offerings that provide smarter ways to communicate and distribute content, manage network and operations remotely, protect and secure investments, and enhance the crew experience and guests. With a passionate customer focus and a strong safety culture, Speedcast serves more than 3,200 customers in more than 140 countries. Learn more at

About Harvest Technology Group
Harvest Technology Group Limited (ASX: HTG) is a global leader in network-optimized remote operations that deliver remote control, communication, automation and real-time monitoring capabilities for the energy industries, renewable resources and energies. Situated at Perth, Australia, the group of companies is revolutionizing remote field services with ultra-low bandwidth network-optimized live streaming solutions that allow customers to stay connected to operations and staff anywhere in the world while using just one fraction of existing bandwidth resources.

For more information, please visit:

If you would like to receive updates from the HTG newsletter, visit the investors page to sign up:

View original content to download multimedia:

SOURCE Harvesting Technology Group

The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.

Source link

GitLab IPO: 5 things to know about the all-remote software publisher that could be valued at over $ 8 billion Mon, 11 Oct 2021 17:14:00 +0000 GitLab Inc. is a fully remote software company expected to reach a valuation of over $ 8 billion in its initial public offering this week.

Gitlab GTLB,

aims to raise up to $ 502.2 million in an offering of 8.4 million shares ranging from $ 55 to $ 60 per share, which would value the company up to $ 8.6 billion. The company filed initial documents for its IPO with the Securities and Exchange Commission in mid-September and is expected to trade on the Nasdaq under the symbol “GTLB” Thursday.

GitLab specializes in so-called DevOps software, which allows software developers and operators to collaborate on projects to deliver faster, more relevant software updates to their internal systems on an almost constant basis. The software enables a company’s development, operations, IT, security and sales teams to work on a common platform.

Goldman Sachs, JP Morgan, B. of A. Securities, UBS Investment Bank and RBC Capital Markets are among the underwriters, and 143 million shares are expected to be outstanding after the offer, or 143.5 million if the options to over-allotments are exercised by the underwriters.

Here are five things to know about the company from its SEC documents.

They have competition

The company said it considers the Atlassian Corp. TEAM,
+ 0.75%
collaboration software such as a competitor Jira, but GitLab’s main competitor is the GitHub of the same name, which was acquired by Microsoft Corp. MSFT,
+ 0.27%
in 2018 for $ 7.5 billion. This could explain why GitLab lists its hyperscale cloud partners as AMZN from Inc.,
GOOGL from AWS and Alphabet Inc.,

Google Cloud, which provides the company’s platform, with the notable absence of Microsoft’s Azure.

GitLab said the market for its DevOps platform is around $ 40 billion, based on data from Gartner. With an infrastructure software market of $ 328 billion at the end of 2021 and $ 458 billion expected by the end of 2024, GitLab estimates that it can serve $ 43 billion of this market by the end of 2021 and $ 55 billion of by the end of 2024.

See also: A bunch of fitness companies have entered the IPO market this year. It does not work.

GitLab claims a steady increase in annual recurring revenue, or ARR, a software as a service metric that shows how much revenue the business can expect based on subscriptions. Core customers – those with $ 5,000 or more in ARR – grew to 3,632 at the end of July, from 2,745 at the end of January and 1,662 at the end of January 2020.

At the end of July, GitLab reported that ARR customers of $ 100,000 or more had increased to 383 from 219 the previous year, and that ARR customers of $ 1 million had increased from 15 to 27.

They were working from home before it got cool

GitLab said it believed it was the largest fully remote company in the world before the COVID-19 pandemic forced many more workers to move away. In fact, on the SEC filing where a company typically lists the physical address of its head office, GitLab lists “Address not applicable.”

GitLab has been “100% remote since its inception” when co-founder Dmitriy Zaporozhets first offered GitLab from his home in Ukraine which didn’t even have running water. CEO and co-founder Sytse Sijbrandi found GitLab from his home in the Netherlands and the two incorporated GitLab in 2014 and became the beneficiary of technology accelerator Y Combinator in 2015.

Read: 5 things to know about Rivian as Amazon-backed electric vehicle maker goes public

With 1,350 employees in more than 65 countries, GitLab said that its remote-only organization “gives us access to a global talent pool that allows us to hire talented team members, regardless of location, offering a strong competitive advantage ”, and allows the company to help other companies manage their newly remote workforce.

This strength, however, is also listed as a risk factor in the company’s S-1 record. GitLab stated that “the technologies in the homes of our team members may not be robust enough and could make networks, information systems, applications and other tools available to team members and limited service providers. , unreliable or insecure “.

They are NOT here to create a “family”

GitLab comes across as very blunt in its S-1, without many of the corporate culture platitudes that many tech companies espouse.

“Some companies talk about being ‘family’,” Sijbrandi said in his letter to investors. “We don’t think this is the right prospect. At GitLab, the relationship is not the end goal. The goal is the results. We are clear about accountability and hold people to a clearly defined standard. When people are not performing, we try to help them improve. If they still can’t meet expectations, we let them go.

For GitLab, “results” mean not doing things differently to be different, using “boring solutions whenever possible”, having a new version of its software on the 22nd of each month and empowering the employee who must do it. work resulting from a decision with the capacity to make that decision.

Lower level services have been discontinued

GitLab said it offers three services: free, “premium” for $ 19 per month for each user and “ultimate” for $ 99 per month for each user.

The company said it has dropped two other paid tiers, starter and bronze, and that those users will have to choose from the three new offerings or stop using GitLab. Customers using startup and bronze tiers accounted for 11% of revenue for the six months ending July 31, up from 16% at year-end 2021 and 27% at year-end 2020.

GitLab reported revenue of $ 152.2 million and loss of $ 192.2 million in 2020, compared with revenue of $ 81.2 million and loss of $ 130.7 million. dollars in 2019. For the first half of 2021, the company reported revenue of $ 108.1 million and loss of $ 68.1 million, compared with revenue of $ 63.9 million and a loss of $ 43.5 million for the first half of 2020.

As with the most recent IPOs, don’t expect votes

The offer is for Class A shares, which receive one vote, compared to Class B shares, which receive 10 votes. Following the offer, Class B shareholders will hold 99.1% of the votes.

GitLab’s venture capital funding began with seed money from Y Combinator and Khosla Ventures in 2015, and after subsequent rounds of funding with other companies, the company raised $ 414.9 million in initial investments, according to Crunchbase.

After the offer, Khosla is expected to have 14.3% of the voting rights, Iconiq Strategic Partners 11.7%, August Capital 11.3% and GV 2017 6.7%. Sijbrandi, who is the CEO of the company he co-founded, will hold 16.7% of the voting rights.

Source link

How to get free help sorting out your options during open enrollment for Medicare Sat, 09 Oct 2021 04:13:10 +0000

Registration for Medicare is now in progress. Medicare has released new information on Medicare Advantage Plans and Part D Drug plans available in 2022.

Open enrollment is an important time of year when people on Medicare should compare their plans to make sure they have the appropriate and most affordable coverage available.

Medicare SHIP, a nonprofit organization, will provide you with comparison assistance at no cost. Medicare SHIP does not sell or endorse any insurance company and will help you make informed decisions about your health insurance needs. In addition, our program may seek you economic benefits, such as Extra Help or Medicare Savings Program, which could save you a lot of money.

Medicare SHIP can help you compare Medicare Advantage plans or Medicare Part D drug plans. Medicare Advantage plans, sometimes referred to as “Part C” or “MA Plans,” are offered by private companies approved by Medicare that sell an alternative. all-in-one bundled with original Medicare.

Often these plans include prescription drug coverage. In addition, the plan becomes your primary medical insurance and is presented to your health care provider when you receive services. Sometimes the plans have additional coverage not offered by the original health insurance, such as limited dental, vision or hearing coverage. However, the plans also have restrictions like supplier networks.

Alternatively, Medicare Part D plans are stand-alone insurance plans that cover your prescription drugs. It’s important to compare your drug coverage each year because plans change their premiums, deductibles, and formulas (the list of drugs they cover). While your plan may have worked well in the past, without comparing your 2022 options, there is no guarantee that this will be the best coverage for you in the New Year!

Medicare open enrollment runs from October 15 to December 7. Don’t delay and call your Medicare SHIP program today for free assistance. Call Medicare SHIP at 1-866-516-3051 or visit to learn more and get information.

Source link

Kathy Urffer: Connecticut River Profits Should Benefit Local Communities Thu, 07 Oct 2021 14:54:00 +0000

This commentary is from Kathy Urffer, river steward for the Connecticut River Conservancy in Vermont and New Hampshire.

The owners of five hydroelectric facilities on the Connecticut River – the Wilder, Bellows Falls and Vernon Dams in Vermont and New Hampshire, and the Northfield Mountain Pumped Storage Project and the Turners Falls Dam in Massachusetts – are seeking new licenses from operating with the Federal Energy Regulatory Commission. that will allow these businesses to continue to enjoy more than 175 miles of the Connecticut River for the next 40 to 50 years.

How much of these profits will go to local communities to support your river?

The three facilities in Vermont and New Hampshire are owned by Great River Hydro, a limited liability subsidiary of ArcLight, a Boston-based private equity firm that invests in energy infrastructure. The Wilder, Bellows Falls and Vernon dams, along with several others on the Connecticut and Deerfield rivers, were previously owned by TransCanada and were sold to ArcLight in 2017.

Since this company is a private limited liability company, the public has little financial information on how Great River Hydro benefits our river. The Connecticut River Conservancy and many other stakeholders want to ensure that in return for this license, the public gets a good deal for the use of their river for the next 40 years.

Great River Hydro says it will spend $ 10.1 million in Wilder, $ 12.5 million in Bellows Falls and $ 12.4 million in Vernon over the next 40 years to reduce impacts on aquatic species and improve river health, public recreational and cultural facilities. That sounds like a lot of money – a total of $ 35.1 million over 40 years, or $ 877,825 per year – but let’s put that in context …

While there are no public reports on the annual income and expenses of these LLCs, some financial information is available from the required disclosures of the company’s FERC license applications filed in 2016 and 2020, valuations of the company. ‘property tax by local cities and public information based on electricity and capacity pricing.

Based on its documents, Great River Hydro indicated that Wilder, Bellows Falls and Vernon collectively achieved $ 27.9 million in revenue in 2016 and $ 33.5 million in 2019. Based on what is reasonable to say. ” include in their reported operating costs this is between $ 1.8 million and $ 18.3 million per year, but they intend to invest only $ 877,825 per year in protective measures and mitigation, such as improved fish passage, improved river access and educational programs for our communities.

These hydropower companies invest for the short term, and as people forget what the companies have promised as a result of the license renewal process, they reap the benefits of the facilities for decades to come.

Let’s not forget that Great River Hydro has worked hard to cut taxes by using its lawyers to arm the cities that host these facilities. For example, the town of Vernon had to enter into a settlement agreement in 2014 to satisfy the appeal of TransCanada (the precursor to Green River Hydro) regarding its 2012, 2013 and 2014 taxes, which froze the assessed value of the installation of Vernon until 2019.

Likewise, Rockingham had to spend four years in court with Great River Hydro to resolve an appeal of its 2012 tax assessment. Until this issue is resolved, Great River Hydro has appealed its 2015 taxes and taxes. 2016 in Rockingham, which led the city to agree to a settlement in 2018 setting the assessed value of the Bellows Falls facility at $ 103.6 million through 2022, even though the outcome of the 2016 lawsuit set valued at $ 127.4 million.

Great River Hydro has proposed a change in how the facilities will operate over the next license, which will help the river and not impact their revenues. A real win-win!

We are not opposed to Great River Hydro making a reasonable return on its investment, but it should only get it after reaching a better deal with the public and our local communities. It means being transparent and telling the full story of your income and expenses and ensuring that that profit returns every year to support our communities and the health of your river for the next 40 years.

Local communities, states and individuals should be prepared to comment on the Federal Energy Regulatory Commission when we have the opportunity to ensure these new licenses help support the river and your local communities. You can learn to express yourself at or at

Source link

Pandora Papers: 3 offshore companies connect a Swiss bank, the best arbitrator and his wife, the Gulf tycoon Wed, 06 Oct 2021 00:20:13 +0000 Hiroo Advani, lawyer and co-founder of Business India magazine, and his wife Nita Hiroo Advani owned two offshore companies in the British Virgin Islands (BVI) and Seychelles, records in the Pandora Papers studied by The Indian Express.

Nita Advani was also co-owner of a third offshore company in the BVI with Tony Jashanmal, group director of a family-owned retail and distribution empire in the Gulf.

Read | On the Pandora Papers List: An IRS Officer and Former Chief IT Commissioner

The records of the Pandora Papers show that a Swiss private bank, Clariden Leu, was authorized to give instructions for the management of the affairs of the three offshore entities. The London address of Clariden Leu has been recorded as the business address of these companies.

Hiroo Advani founded Advani & Co, India’s “oldest specialist arbitration practice” in 1986. The law firm’s website describes him as a “world authority on arbitration law” and “one of only two Indian lawyers ever listed in the International Who’s Who of Commercial Arbitrators”.

Previously, together with his brothers Ashok and Rajkumar, he had founded Business India, a bimonthly, in 1978.

Alcogal’s records identify Nita Hiroo Advani as the beneficial owner of Batheath Ltd in the British Virgin Islands.

According to Indian Companies Register (RoC) records, Nita Hiroo Advani has been the Director since 2006 of Chryssa Real Estate Pvt Ltd in Mumbai (with a 99.9% stake). The records also show a different director identification number for Nita Hiroo Advani for her listing as a director in Narayani Properties And Estate Developers Pvt Ltd in Goa (with a 95% stake).

Holder of an Indian passport, Jhangiani Tony Naraindas Jashanmal runs the Jashanmal group which began its journey in 1919 when his grandfather established his first department store in Basra, Iraq.

🗞 Read the best investigative journalism in India. Subscribe to the Indian Express e-Paper here.

Today, the group operates more than 150 stores in the United Arab Emirates, Kuwait, Bahrain and Oman, as well as a distribution network of consumer goods and services spanning more than 1,000 points of sale. .

On May 3, 2010, Hiroo and Nita provided details of compliance as beneficial owners of Lidcote Ltd, a company incorporated in BVI, and Faraday International Limited, which was incorporated in Seychelles.

On the same day, Nita and Tony Jashanmal provided details of compliance as beneficial owners of Batheath Ltd, which was incorporated in BVI.

Read | Hiranandani, Mumbai Real Estate Major: Link to BVI, Trust with $ 60 Million in Assets

Lidcote (BVI) was established in December 2006, Batheath (BVI) in March 2008 and Faraday International (Seychelles) in December 2008.

In compliance cases, Advanis and Jashanmal were represented by Clariden Leu Asset Management (UK) Ltd, a subsidiary of Credit Suisse until its acquisition by Swiss wealth management firm Falcon Private Bank in 2013.

The Advanis and Jashanmals declared inheritance, personal and business property as a source of funds for these businesses.

Read | After Panama, it’s Pandora: in the face of regulatory heat, Indian elites are finding new ways to protect their wealth in secret havens

In addition to serving as holding and investment companies, these three entities have listed businesses on offer ranging from real estate, oil and mining to money transfer and jewelry. The beneficiaries used directors, secretaries and shareholders for all three companies.

In a resolution of July 5, 2010, Faraday International (Seychelles) recorded that “the Company borrows from Clariden Leu Ltd and has pledged (all / part) of its assets held with Clariden Leu Ltd as collateral” on May 11, 2010.

Earlier in February 2009, Clariden Leu wrote to business service provider Cook Worldwide on behalf of Hiroo Advani for the establishment of a Mauritius company as a wholly owned subsidiary of Batheath Limited (BVI). This communication was copied to Hiroo Advani.

One of the goals of the proposed Mauritian company, Clariden Leu wrote, would be “to invest in real estate investments, including hotel and hotel projects in India”.

In 2017, the exhibition records, the two BVI companies – Batheath Limited and Lidcote Limited – were struck off the register. Faraday International (Seychelles) was due to be struck off in June 2016, but its status remains unclear.

In an email response to questions from The Indian Express, Hiroo Advani said, “These are NRI client companies and as far as I know the clients shut them down about 10 years ago. Do not have any other information because I did not keep old files. Nita Advani has never had a stake in Batheath Ltd (BVI). Tony Jashanmal has been a businessman in the Gulf for 50 years and I am not aware of his business connections. Nita Advani’s national businesses are all local businesses and all returns have been filed and taxes paid.

Read more | Pandora Papers: Singaporean company of HealthifyMe owner linked to former Putin aide’s fund

In an email response, Jashanmal said, “I am a non-resident Indian and have lived and run business outside of India for over 50 years. I have no recollection of ever having a Batheath Limited (BVI) offshore company.

“Anyway, it’s so long ago and even I had such a company that it was never activated and couldn’t have funds over $ 100. Have held no shares with Nita Hiroo Advani and never in the past and present has any kind of commercial interest, ownership or other business relationship with her, ”he said.

Source link

$ 5.99 Antimicrobial Susceptibility Testing Marketplace Tue, 05 Oct 2021 11:26:42 +0000

Redding, Calif., October 5, 2021 (GLOBE NEWSWIRE) – According to a new market research report titled,Antimicrobial Susceptibility Testing Market by product (manual {sensitivity discs, plates, MIC strips}, consumables, automated), method (diffusion, dilution), application (clinical diagnostics), end user (hospitals, pharmacy, institutes) – Forecast until 2028 ”, published by Meticulous Research®, the antimicrobial susceptibility testing market is expected to grow at a CAGR of 6.4% from 2021 to 2028 to reach $ 5.99 billion by 2028.

Download a Free Sample Report Now @

Antimicrobial susceptibility testing (AST) is one of the vital tasks performed in clinical microbiology laboratories. The main objective of these tests is to detect possible drug resistance in common pathogens and to ensure sensitivity to the drugs of choice for a particular type of infection. In recent years, increasing resistance to antibiotics has led to a growing demand for antimicrobial susceptibility testing. The growth of this market is mainly attributed to the high prevalence of infectious diseases, the development of automated and manual products for AST, the increase in government initiatives and funding of AST programs, technological advancements towards the development of new AST methods and the emergence of multidrug resistance. in microorganisms. Emerging markets and active R&D to develop rapid antimicrobial susceptibility testing are expected to offer significant growth opportunities for players operating in the antimicrobial susceptibility testing market. However, strict government regulations are expected to hamper the growth of this market to some extent. On the other hand, the high cost of automated antimicrobial susceptibility testing systems and the problems of antimicrobial resistance surveillance in low- and middle-income countries pose challenges for the industry.

The overall antimicrobial susceptibility testing market is segmented on the basis of product, method, application, end use, and geography.

Talk to our analysts to understand the impact of COVID-19 on your business:

Based on the product, the antimicrobial susceptibility testing market is segmented into manual AST products, automated AST products, and consumables. In 2021, the manual AST products segment is expected to account for the largest share of the overall antimicrobial susceptibility testing market. The growth of this market is due to the inexpensive nature of manual AST products, the simple handling procedures of these products, the increasing incidence of antibacterial resistance, the availability of a diverse range of consumables for manual testing. and the ease of interpretation of these tests.

On the basis of the method, the antimicrobial susceptibility testing market is segmented into disk diffusion, automated AST, dilution, and other methods. In 2021, the disk delivery segment is expected to account for the largest share of the overall antimicrobial susceptibility testing market. The advantages of the disk diffusion method are the simplicity of the test which does not require any special equipment, the provision of categorical results easily interpreted by any clinician and the flexibility in the selection of the disks to be tested. The low cost of AST tests with the disk diffusion methods and the method developments with automated technology are mainly driving the market growth of the segment.

Based on the applications, the antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, and other applications. In 2021, the clinical diagnostics segment is expected to represent the largest share of the global antimicrobial susceptibility testing market. The large share is mainly attributed to the growing burden of antibiotic resistance, the increasing incidence of HAIs, the increasing volume of clinical diagnostic testing procedures, the increasing emphasis on the effective and early diagnosis of diseases on major markets and increasing physician awareness of antimicrobial susceptibility testing methods. .

Quick purchase – Antimicrobial Susceptibility Testing Market Research Report:

Based on the end user, the antimicrobial susceptibility testing market is segmented into diagnostic laboratories and hospitals, pharmaceutical and biotechnology companies, and research institutes and academics. In 2021, the diagnostic laboratory and hospital segment is expected to account for the largest share of the overall antimicrobial susceptibility testing market. The large share of this segment is mainly attributed to the availability of well-equipped facilities and trained / competent technicians and the increase in cases of nosocomial infections.

On the basis of geography, the global antimicrobial susceptibility testing market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. In 2021, North America is estimated to account for the largest share of the global antimicrobial susceptibility testing market, followed by Europe and Asia-Pacific. The significant share of the North American region is attributed to increased healthcare spending, increased investment in pharmaceutical R&D, and the availability of advanced susceptibility testing methods. However, Asia Pacific is expected to grow at the highest CAGR of 8.4% due to increasing cases of antibiotic resistance and heightened awareness of antimicrobial susceptibility testing.

Some of the major players operating in the global antimicrobial susceptibility testing market include Merck KGaA (Germany), bioMérieux SA (France), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Alifax Srl (Italy), Synbiosis (UK) and Zhuhai DL Biotech Co., Ltd (China) among others. New product launches, enhancements, approvals and agreements are some of the key strategies adopted by players to expand their service offerings, global footprint and increase market share. For example, in July 2020, the company launched Xpert MTB / XDR, a rapid molecular test for tuberculosis, and detects resistance to first and second-line drugs. Likewise, in October 2019, Becton, Dickinson and Company (US), as well as Check-Points Health BV (Netherlands), received 510 (k) clearance from the FDA for a molecular screening test for Antibiotic Resistant Carbapenemase (OPC) Producing Organisms on the Fully Automated BD MAX System. The BD MAX Check-Points CPO Assay enables detection of carbapenemase genes directly from patient samples and improved turnaround time.

To better understand the market with a table of contents and detailed figures, click here:

Scope of the report:

Antimicrobial Susceptibility Testing Market, by product

  • Manual Antimicrobial Susceptibility Testing Products
    • Sensitivity discs
    • Susceptibility plates
    • Minimum Inhibitory Concentration (MIC) strips
  • Consumables
  • Automated Antimicrobial Susceptibility Testing Products

Antimicrobial Susceptibility Testing Market, By Method

  • Diffusion Disc
  • Automated AST
  • Dilution
  • Other methods

Other methods include Etest, genotypic methods, and MALDI-TOF MS.

Antimicrobial Susceptibility Testing Market, By Application

  • Clinical diagnosis
  • Drug discovery and development
  • Other applications

(Other applications include epidemiology, veterinary diagnostics, and environmental monitoring)

Antimicrobial Susceptibility Testing Market, By End User

  • Diagnostic laboratories and hospitals
  • Pharmaceutical and biotechnology companies
  • Research institutes and universities

Antimicrobial Susceptibility Testing Market, by geography

  • North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa

Download a Free Sample Report Now @

In the midst of this crisis, Meticulous Research® Continuously assesses the impact of the COVID-19 pandemic on various submarkets and enables global organizations to strategize for the post-COVID-19 world and support their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-

Associated reports

Blood Screening Market by Product (Reagents and Kits, Instruments, Software), Technology (NAAT [Real-time PCR], ELISA [CLIA, FIA, CI], rapid tests, Western Blot, NGS) and end user (blood banks, hospitals, laboratories) – Global forecast to 2027

Infectious disease diagnostics market by product and solution (consumables, system, software and services), technology (immunodiagnostics, PCR, INAAT), disease (HIV, HAIS, influenza), end user (hospital, reference laboratory, research) – Global forecasts for 2027

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a limited liability company under the Companies Act of 1956. Since its incorporation, the company has grown into the leading provider of high-end market information in North America, Europe, Asia- Pacific, Latin America, Middle East and Africa. .

The name of our company defines our services, our strengths and our values. From the beginning, we have only made an effort to research, analyze and present critical market data with great attention to detail. Through meticulous primary and secondary research techniques, we have developed strong capabilities in data collection, interpretation and analysis, including qualitative and quantitative research with the best team of analysts. We design our market research reports, personalized studies, rapid research and consulting solutions, intelligent and value-driven, meticulously analyzed to meet the business challenges of sustainable growth.

Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis Street, 200 Redding Street,
California, 96001, United States
United States: + 1-646-781-8004
Europe: + 44-203-868-8738
APAC: +91 744-7780008
Visit our website:
Connect with us on LinkedIn-
Source of content:

Source link